miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells
Author:
Affiliation:
1. Department of Gynecology and Obstetrics; The Fourth Clinical Hospital of Harbin Medical University; Harbin Heilongjiang China
2. Department of Gynecology; The Hospital of Heilongjiang Province; Nangang Branch; Harbin Heilongjiang China
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13104/fullpdf
Reference44 articles.
1. Global cancer statistics;Jemal;CA Cancer J Clin,2011
2. Treatment of metastatic cervical cancer: future directions involving targeted agents;Diaz-Padilla;Crit Rev Oncol Hematol,2013
3. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer;Lorusso;Gynecolo Oncol,2014
4. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes;Shen;Pharmacol Rev,2012
5. Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells;Castellanos;OncoTargets Ther,2013
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses;Frontiers in Cell and Developmental Biology;2024-08-28
2. A comprehensive review on the functional role of miRNA clusters in cervical cancer;Epigenomics;2024-03-29
3. YB-1 Targeted by miR-509-3-5p Affects Migration and Invasion of Triple‑Negative Breast Cancer by Regulating Cellular Epithelial‑Mesenchymal Transition;Molecular Biotechnology;2024-03-04
4. Extracellular vesicle-encapsulated miR-25-3p promotes epithelial–mesenchymal transition and migration of endometrial epithelial cells by inducing macrophage polarization;Molecular Human Reproduction;2024-02-24
5. Expression patterns and pathogenesis of Semaphorin class 4 subfamily proteins in solid tumors;NEOPLASMA;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3